Učitavanje...
p38MAPK and Chemotherapy: We Always Need to Hear Both Sides of the Story
The p38MAPK signaling pathway was initially described as a stress response mechanism. In fact, during previous decades, it was considered a pathway with little interest in oncology especially in comparison with other MAPKs such as ERK1/2, known to be target of oncogenes like Ras. However, its involv...
Spremljeno u:
| Izdano u: | Front Cell Dev Biol |
|---|---|
| Glavni autori: | , , , , , , |
| Format: | Artigo |
| Jezik: | Inglês |
| Izdano: |
Frontiers Media S.A.
2016
|
| Teme: | |
| Online pristup: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4928511/ https://ncbi.nlm.nih.gov/pubmed/27446920 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3389/fcell.2016.00069 |
| Oznake: |
Dodaj oznaku
Bez oznaka, Budi prvi tko označuje ovaj zapis!
|